[ad_1]

wildpixel/iStock via Getty Images
As Medicare announced a fresh set of drugs selected for its price-setting process on Friday under the Inflation Reduction Act, industry group PhRMA criticized the landmark legislation, arguing that it has failed to regulate pharmacy benefit managers and insurers, which it said “are the
[ad_2]